PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population

American Journal of Human Genetics

Volumn 60, Issue 4, 1997, Pages 935-947

  Grody, Wayne W ^a,b   Dunkel Schetter, Christine ^b   Tatsugawa, Zina H ^a   Fox, Michelle A ^a,b   Fang, Carolyn Y ^b   Cantor, Rita M ^c   Novak, Jessica M ^a   Bass, Harold N ^a,b,d   Crandall, Barbara F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CYSTIC FIBROSIS; ETHNOLOGY; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SATISFACTION; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; CALIFORNIA; CYSTIC FIBROSIS; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH MAINTENANCE ORGANIZATIONS; HETEROZYGOTE; HUMANS; INFORMED CONSENT; KNOWLEDGE; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PSYCHOLOGY, SOCIAL; RESEARCH DESIGN;

EID: 0030960787     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Ajzen I (1985) From intentions to actions: a theory of planned behavior. In: Kuhl J, Beckmann J (eds) Action control: from cognition to behavior. Springer, Berlin, pp 11-38
2. American Society of Human Genetics, The (1992) Statement of The American Society of Human Genetics on cystic fibrosis carrier screening. Am J Hum Genet 51:1443-1444
3. Asch DA, Patton JP, Hershey JC, Mennuti MT (1993) Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol 168:1-6
4. Beaudet AL (1990) Carrier screening for cystic fibrosis. Am J Hum Genet 47:603-605
5. Bekker H, Dennis G, Modell M, Bobrow M, Marteau T (1994) The impact of population based screening for carriers of cystic fibrosis. J Med Genet 31:364-368
6. Biesecker L, Bowles-Biesecker B, Collins F, Kaback M, Wilfond B (1992) General population screening for cystic fibrosis is premature. Am J Hum Genet 50:438-439
7. Billings PR, Kohn MA, de Cuervas M, Beckwith J, Alper JS, Natowicz MR (1992) Discrimination as a consequence of genetic testing. Am J Hum Genet 50:476-482
8. Blitzer MG, McDowell GA (1992) Tay-Sachs disease as a model for screening inborn errors. Clin Lab Med 12:463-480
9. Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th ed. McGraw-Hill, New York, pp 2649-2680
10. Brock D (1990) Population screening for cystic fibrosis. Am J Hum Genet 47:164-165
11. Caskey CT, Kaback MM, Beaudet AL (1990) The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet 46:393
12. Chapple JC, Dale R, Evans BG (1987) The new genetics: will it pay its way? Lancet 1:1189-1192
13. Chehab FF, Wall J (1992) Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum Genet 89:163-168
14. Childs B, Gordis L, Kaback MM, Kazazian HH (1976a) Tay-Sachs screening: motives for participating and knowledge of genetics and probability. Am J Hum Genet 28:537-549
15. _ (1976b) Tay-Sachs screening: social and psychological impact. Am J Hum Genet 28:550-558
16. Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW III, Phillips JA III (1996) Lack of interest by non-pregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet 58:617-627
17. Crystal RG, McElvaney NG, Rosenfeld MA, Chu C-S, Mastrangeli A, Hay JG, Brody SL, et al (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8:42-51
18. Curtis A, Richardson RJ, Boohene J, Jackson A, Nelson R, Bhattacharya SS (1993) Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. J Med Genet 30:164-166
19. Cutting GR, Curristin SM, Nash E, Rosenstein BJ, Lerer I, Abeliovich D, Hill A, et al (1992) Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet 50:1185-1194
20. Cystic Fibrosis Foundation (1986) Report on the patient registry. Cystic Fibrosis Foundation, Rockville, MD
21. Cystic Fibrosis Genetic Analysis Consortium, The (1990) Worldwide survey of the ΔF508 mutation - report from the Cystic Fibrosis Genetic Analysis Consortium. Am J Hum Genet 47:354-359
22. Davies K (1992) Genetic screening for cystic fibrosis. Nature 357:424a
23. DeMarchi JM, Beaudet AL, Caskey CT, Richards CS (1994) Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations. Arch Pathol Lab Med 118:26-32
24. Doherty R, Palomaki G, Kloza E, Erickson J, Dostal D, Haddow J (1994) Couple-based prenatal cystic fibrosis screening in primary care offices in Maine. Am J Hum Genet Suppl 55:A278
25. Fang CY, Dunkel-Schetter C, Tatsugawa ZH, Fox MA, Bass HN, Crandall BF, Grody W. Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style. Womens Health Res Gender Behav Policy (in press)
26. Gilbert F (1990) Is population screening for cystic fibrosis appropriate now? Am J Hum Genet 46:394-395
27. Gostin L (1990) Genetic discrimination: the use of genetically based diagnostic and prognostic tests by employers and insurers. Am J Law Med 17:109-144
28. Grebe TA, Doane WW, Richter SF, Clericuzio C, Norman RA, Seltzer WK, Rhodes SN, et al (1992) Mutation analysis of the cystic fibrosis transmembrane regulator gene in Native American populations of the southwest. Am J Hum Genet 51:736-740
29. Grebe TA, Seltzer WK, DeMarchi J, Silva DK, Doane WW, Gozal D, Richter SF, et al (1994) Genetic analysis of Hispanic individuals with cystic fibrosis. Am J Hum Genet 54: 443-446
30. Hannig VL, Clayton EW, Pfotenhauer JP, Miller CS, Parker RA, Campbell PW III, Grimm PV, et al (1994) Efficacy of written and video educational approaches for cystic fibrosis carrier screening. Am J Hum Genet Suppl 55:A142
31. Harris H, Scotcher D, Hartley N, Wallace A, Craufurd D, Harris R (1993) Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ 306:1580-1583
32. Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, Wu M, et al (1992) A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 326:812-815
33. Jung U, Urner U, Grade K, Coutelle C (1994) Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population. Hum Genet 94:19-24
34. Kerem E, Lynch A (1991) Screening for cystic fibrosis: ethical and social issues. Am Rev Respir Dis 143:457-460
35. Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080
36. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, et al (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831
37. Kwok S (1990) Procedures to minimize PCR-product carry-over. In: Innes MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego, pp 142-145
38. Livingstone J, Axton RA, Gilfillan A, Mennie M, Compton M, Liston WA, Calder AA, et al (1994) Antenatal screening for cystic fibrosis: a trial of a the couple model. BMJ 308: 1459-1462
39. Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH Jr, Rowley PT (1996) Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet 59:234-247
40. Loader S, Sutera CJ, Walden M, Kozyra A, Rowley PT (1991) Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet 48:447-451
41. McCrae WM, Cull, AM, Burton L, Dodge J (1973) Cystic fibrosis: parents' response to the genetic basis of the disease. Lancet 2:141-143
42. Mennie ME, Compton ME, Gilfillan A, Liston WA, Pullen I, Whyte DA, Brock DJH (1993a) Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet 30:543-548
43. Mennie ME, Gilfillan A, Compton M, Curtis L, Liston WA, Pullen I, Whyte DA, et al (1992) Prenatal screening for cystic fibrosis. Lancet 340:214-216
44. Mennie ME, Gilfillan A, Compton ME, Liston WA, Brock DJH (1993b) Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing. Prenat Diagn 13:807-814
45. Miedzybrodzka Z, Dean J, Haites N (1991) Screening for cystic fibrosis. Lancet 338:1524-1525
46. Miedzybrodzka Z, Hall MH, Mollison J, Templeton A, Russell IT, Dean JCS, Kelly KF, et al (1995) Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ 310:353-357
47. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad PB, et al (1992) Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2:159-163
48. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, et al (1989) Cloning and characterization of complementary DNA. Science 245:1066-1073
49. Rommens JM, Iannuzzi MC, Kerem B-S, Drumm ML, Melmer G, Dean M, Rozmahel R, et al (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065
50. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, et al (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155
51. Rosenstock IM (1966) Why people use health services. Milbank Mem Fund Q Suppl 44:94-127
52. Sachs L (1982) Applied statistics: a handbook of techniques. Springer, New York
53. Saiki RK, Walsh PS, Levenson CH, Erlich HA (1989) Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 86: 6230-6234
54. Schulman JD, Maddalena A, Black SH, Bick DP (1990) Screening for cystic fibrosis carriers. Am J Hum Genet 47:740
55. Shuber AP, Skoletsky J, Stern R, Handelin BL (1993) Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis. Hum Mol Genet 2:153-158
56. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH (1992) An animal model for cystic fibrosis made by gene targeting. Science 257: 1083-1088
57. Spielberger CD (1985) Assessment of state and trait anxiety: conceptual and methodological issues. South Psychol 2:6-16
58. Tambor ES, Bernhardt BA, Chase GA, Faden RR, Geller G, Hofman KJ, Holtzman NA (1994) Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet 55:626-637
59. Tatsugawa ZH, Fox MA, Fang CY, Novak JM, Cantor R, Bass HN, Dunkel-Schetter C, et al (1994) Education and testing strategy for large-scale cystic fibrosis carrier screening. J Genet Couns 3:279-289
60. ten Kate LP (1990) Carrier screening for cystic fibrosis and other autosomal recessive diseases. Am J Hum Genet 47: 359-361
61. Thomson DM, Brown NN, Clague AE (1992) Routine use of hair root or buccal swab specimens for PCR analysis: advantages over using blood. Clin Chim Acta 207:169-174
62. Wald NJ 1991) Couple screening for cystic fibrosis. Lancet 338:1318-1319
63. Wall J, Cai S, Chehab FF (1995) A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 5:333-338
64. Walsh PS, Metzger DA, Higuchi R (1991) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 10:506-513
65. Watson EK, Mayall E, Chapple J, Dalziel M, Harrington K, Williams C, Williamson R (1991) Screening for carriers of cystic fibrosis through primary health care services. BMJ 303:504-507
66. Watson EK, Mayall ES, Lamb J, Chapple J, Williamson R (1992) Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet 340: 217-220
67. Weil J (1991) Mothers' postcounseling beliefs about the causes of their children's genetic disorders. Am J Hum Genet 48: 145-153
68. Whitten CF (1973) Sickle-cell programming - an imperiled promise. N Engl J Med 288:318-319
69. Whitten CF, Thomas JF, Nishiura EN (1981) Sickle cell trait counseling: evaluation of counselors and counselees. Am J Hum Genet 33:802-816
70. Wilfond BS, Post N (1990) The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 263:2777-2783
71. _ (1992) The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations. Milbank Q 70:629-659
72. Williamson R (1993) Universal community carrier screening for cystic fibrosis? Nat Genet 3:195-201
73. Witt D, Fitzgerald P, Schaefer C (1993) Long term follow-up of attitudes, perceptions, and psychological effects of prenatal screening for cystic fibrosis heterozygotes. Am J Hum Genet Suppl 53:49
74. Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A, Holtzman J, et al (1996) Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 58: 823-835
75. Workshop on Population Screening for the Cystic Fibrosis Gene (1990) Statement from the National Institutes of Health workshop on population screening for the cystic fibrosis gene. N Engl J Med 323:70-71
76. Yuen J, Hsia YE, Hall J (1988) Thalassemia heterozygotes in Hawaii: ethnic attitudes toward screening and prenatal diagnosis. Hemoglobin 12:801-816
77. Zeesman S, Clow CL, Cartier L, Scriver CR (1984) A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet 18:769-778